These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3241500)

  • 21. Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung.
    Bjermer L; Engström-Laurent A; Lundgren R; Rosenhall L; Hällgren R
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):803-6. PubMed ID: 3119050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.
    Milman N; Kristensen MS; Bentsen K; Grode G; Frederiksen J
    Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procollagen-III in serum, plasminogen activation and fibronectin in bronchoalveolar lavage fluid during and following irradiation of human lung.
    Maasilta P; Salonen EM; Vaheri A; Kivisaari L; Holsti LR; Mattson K
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):973-80. PubMed ID: 1850723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The carboxyterminal propeptide of procollagen type I (PICP) in serum and biological fluids.
    Risteli L
    Scand J Clin Lab Invest Suppl; 1990; 202():143-6. PubMed ID: 2075430
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased procollagen type III peptide in serum of rabbits exposed to diesel engine exhaust.
    Suzuki T; Kanoh T
    Bull Environ Contam Toxicol; 1990 May; 44(5):700-6. PubMed ID: 1693093
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts].
    Behr J; Adelmann-Grill BC; Hein R; Schwaiblmair M; Degenkolb B; Krombach F; Fruhmann G
    Pneumologie; 1995 Apr; 49(4):266-72. PubMed ID: 7792285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum procollagen III peptide levels in subjects with sarcoidosis. A 5-year follow-up study.
    Pohl WR; Thompson AB; Köhn H; Losch S; Umek H; Legenstein E; Kummer F; Rennard SI; Klech H
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):412-7. PubMed ID: 1310576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Type III procollagen N-terminal aminopeptide and type IV collagen 7S in pleural effusion fluid].
    Tsuchiya Y; Nishikawa M; Iwamoto K; Kirioka T; Noguchi M; Watanabe A; Nishiwaki K; Nozaki Y; Nakane Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):622-6. PubMed ID: 9294295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchoalveolar mastocytosis in farmer's lung is related to the disease activity.
    Bjermer L; Engström-Laurent A; Lundgren R; Rosenhall L; Hällgren R
    Arch Intern Med; 1988 Jun; 148(6):1362-5. PubMed ID: 3377620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease.
    Gilligan DM; O'Connor CM; Ward K; Moloney D; Bresnihan B; FitzGerald MX
    Thorax; 1990 Aug; 45(8):591-6. PubMed ID: 2169654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous measurement of collagen type-VI-related antigen and procollagen type-III-N-propeptide levels in bronchoalveolar lavage.
    Schaberg T; Orzechowski K; Oesterling C; Lode H; Schuppan D
    Eur Respir J; 1994 Jul; 7(7):1221-6. PubMed ID: 7925898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The changes in collagen contents and its clinical significance in chronic obstructive pulmonary disease].
    Dong B; Zhou J; Wang Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):301-2, 319. PubMed ID: 8762485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of various cytokines and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis: inverse correlation between type III procollagen aminopeptide and interferon-gamma in progressive patients.
    Kuroki S; Ohta A; Sueoka N; Katoh O; Yamada H; Yamaguchi M
    Br J Rheumatol; 1995 Jan; 34(1):31-6. PubMed ID: 7881835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis.
    O'Connor C; Odlum C; Van Breda A; Power C; Fitzgerald MX
    Thorax; 1988 May; 43(5):393-400. PubMed ID: 2848327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of serum type III procollagen peptide level in the diagnosis of lung fibrosis developed during bleomycin treatment in cancer patients].
    Okazaki I; Miura K; Ohya S; Murakami M; Nagata N; Maruyama K; Kobayashi T; Okuno F; Oda S; Ito H
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2104-11. PubMed ID: 2419464
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic values of type III Procollagen N-terminal peptide and combination assay of type III procollagen N-terminal peptide with CEA and CA 19-9 in gastric cancer].
    Akazawa S; Harada A; Futatsuki K
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1434-8. PubMed ID: 6588922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease.
    Schuppan D; Besser M; Schwarting R; Hahn EG
    J Clin Invest; 1986 Jul; 78(1):241-8. PubMed ID: 3722378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated lavage levels of N-terminal peptide of type III procollagen are associated with increased fatality in adult respiratory distress syndrome.
    Clark JG; Milberg JA; Steinberg KP; Hudson LD
    Chest; 1994 Mar; 105(3 Suppl):126S-127S. PubMed ID: 8131607
    [No Abstract]   [Full Text] [Related]  

  • 39. Distribution of bronchoalveolar cells and fibronectin levels in bronchoalveolar lavage fluids from patients with lung disorders.
    Nakstad B; Boye NP; Lyberg T
    Scand J Clin Lab Invest; 1990 Oct; 50(6):587-93. PubMed ID: 2247765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term and long-term effects of serial bronchoalveolar lavages in a nonhuman primate model.
    Krombach F; Fiehl E; Burkhardt D; Rienmüller R; König G; Adelmann-Grill BC; Idel H; Rosenbruch M
    Am J Respir Crit Care Med; 1994 Jul; 150(1):153-8. PubMed ID: 8025742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.